Dr. Tom Reynolds
Dr. Tom Reynolds has been appointed on to the Board of Directors at MEI Pharma.
Reynolds has recently retired from his role of Chief Medical Officer at Seattle Genetics which he held from 2007. Prior to that he served as Vice-President at ZymoGenetics (acquired by Bristol-Myers Squibb in 2010).
"His appointment is particularly timely as we prepare for the expansion of our clinical development program for Pracinostat in the months ahead," said Daniel P. Gold, President and CEO of MEI Pharma.